Docebo (NASDAQ: DCBO) retires 10.2% of shares in US$60M bid
Rhea-AI Filing Summary
Docebo Inc. reported the preliminary results of its substantial issuer bid to repurchase common shares. The company expects to buy for cancellation 2,941,176 Common Shares at US$20.40 per share, for aggregate consideration of US$60,000,000.
The shares expected to be purchased represent approximately 10.2% of issued and outstanding Common Shares on a non-diluted basis as of February 1, 2026. After the transaction, approximately 25,819,890 Common Shares are expected to be issued and outstanding.
The offer was oversubscribed, with shareholders (other than odd-lot holders) expected to have about 74.52% of their successfully tendered shares purchased. Intercap Inc. is expected to have 372,612 shares acquired under the offer and to beneficially own 15,913,352 shares, or about 61.6% of the company, following completion.
Positive
- Meaningful capital return and share reduction: Docebo expects to repurchase and cancel 2,941,176 shares at US$20.40, deploying US$60,000,000 and reducing its share count by about 10.2% relative to February 1, 2026, which can enhance per-share metrics if fundamentals remain stable.
Negative
- None.
Insights
Docebo completes a sizable issuer bid, retiring about a tenth of its shares.
Docebo conducted a substantial issuer bid to repurchase up to US$60,000,000 of common shares at US$20.40. Based on preliminary counts, it expects to cancel 2,941,176 shares, equal to about 10.2% of shares outstanding as of February 1, 2026.
The offer was oversubscribed, so tenders are subject to proration, with roughly 74.52% of successfully tendered shares (excluding odd lots) expected to be purchased. This reduces the public float and increases relative ownership stakes for remaining holders.
Intercap Inc., already a majority shareholder, is expected to have 372,612 shares taken up and to beneficially own 15,913,352 shares, or about 61.6% of outstanding shares after completion. This further concentrates control, and future disclosures in company filings may provide more detail on capital allocation and governance considerations.